Eli Lilly and Company
USD1229.93
+21.81 (+1.81%)
CEO
David A. Ricks
IPO Date
1972-06-01
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$1222.78
Prev. Close
$1208.12
Day Low
$1203.14
Day High
$1238.00
52W Low
$623.78
52W High
$1238.00
Market Cap
$1158.28B
Volume
2.89M
| 65.7 |
| 31 Dec 2023 | FY | 79.2% | 15.4% | 48.6% | 8.2% | 2.34 | 0.94 | 100.0 |
| 31 Dec 2022 | FY | 76.8% | 21.9% | 58.6% | 12.6% | 1.52 | 1.05 | 55.7 |
| 31 Dec 2021 | FY | 74.2% | 19.7% | 62.2% | 11.4% | 1.88 | 1.23 | 47.2 |
| 31 Dec 2020 | FY | 77.7% | 25.2% | 109.8% | 13.3% | 2.94 | 1.40 | 26.1 |
| 31 Dec 2019 | FY | 78.8% | 37.3% | 319.1% | 21.2% | 6.06 | 1.16 | 15.1 |
| 31 Dec 2018 | FY | 78.2% | 15.0% | 32.9% | 7.4% | 1.05 | 1.73 | 36.8 |
| 31 Dec 2017 | FY | 77.7% | -1.0% | -1.8% | -0.5% | 1.18 | 1.32 | -435.3 |
| 31 Dec 2016 | FY | 73.1% | 12.9% | 19.5% | 7.1% | 0.74 | 1.37 | 29.6 |
| 36.4 |
| 30 Sept 2025 | Q3 | 82.9% | 31.7% | 23.5% | 4.9% | 1.79 | 1.55 | 30.6 |
| 30 Jun 2025 | Q2 | 84.3% | 36.4% | 31.0% | 5.6% | 2.18 | 1.28 | 30.9 |
| 31 Mar 2025 | Q1 | 82.5% | 21.7% | 17.5% | 3.1% | 2.44 | 1.37 | 67.2 |
| 31 Dec 2024 | Q4 | 82.2% | 32.6% | 31.1% | 5.6% | 2.37 | 1.15 | 39.3 |
| 30 Sept 2024 | Q3 | 81.0% | 8.5% | 6.8% | 1.3% | 2.19 | 1.27 | 205.7 |
| 30 Jun 2024 | Q2 | 80.8% | 26.3% | 21.9% | 4.1% | 2.13 | 1.11 | 69.4 |
| 31 Mar 2024 | Q1 | 80.9% | 25.6% | 17.5% | 3.5% | 2.05 | 1.35 | 76.4 |
| 31 Dec 2023 | Q4 | 80.9% | 23.4% | 20.3% | 3.4% | 2.34 | 0.94 | 59.9 |